Gilead Sciences, Inc. (GILD) has a market capitalization of $174.33B and trades at $140.45. The 52-week range is 93.37-157.29.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 20.5, Earnings Per Share (EPS) of $6.84, annual revenue of $29.44B.
The stock has a beta of 0.40, a last dividend of $3.1900, operates in the Healthcare sector.
